The immune response in chronic hepatitis B virus infection: The “Core” of the problem?
Article first published online: 5 DEC 2005
Copyright © 1992 American Association for the Study of Liver Diseases
Volume 16, Issue 2, pages 498–500, August 1992
How to Cite
Baker, J. R. (1992), The immune response in chronic hepatitis B virus infection: The “Core” of the problem?. Hepatology, 16: 498–500. doi: 10.1002/hep.1840160233
- Issue published online: 5 DEC 2005
- Article first published online: 5 DEC 2005
Individuals with chronic hepatitis B virus (HBV) infection are generally divided into asymptomatic healthy carriers and patients with chronic liver disease. Several studies have suggested that the hepatitis B core antigen could be an immunological target of cytotoxic T lymphocytes (CTL). To investigate the possible pressure site from CTL, the entire core region of HBV DNA was sequenced in 30 subjects (10 asymptomatic healthy carriers and 20 patients with chronic liver disease). No significant changes in the nucleotide sequence and deduced amino acid residue were noted in the 10 healthy carriers. In contrast, a cluster of changes in a small segment of 18 amino acids (codons 84–101 from the start of the core gene) was found in 15 of the 20 chronic liver disease patients. All these 15 patients had advanced liver diseases (chronic active hepatitis and cirrhosis), whereas only mild liver disease (chronic persistent hepatitis) was found in the five patients without mutations. These data suggest that the region with mutation clustering is the major target of CTL, and that the mutations evolve under the pressure of immune selection.